Search

everythinglearnresearchcommunity

for

Search:↓

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Ketoconazole cream is effective for skin conditions like seborrheic dermatitis and may help with hair loss and other skin issues, with generally mild side effects.

Finasteride 1.25 mg showed small improvements in hair density and thickness for female pattern hair loss, but more research is needed.

Platelet-rich plasma (PRP) may help with various hair loss types, but more research is needed to find the best use method.

Media coverage increased public interest in oral minoxidil for hair loss but may also spread misinformation.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Platelet-rich fibrin helps in healing and rejuvenation but results vary and can take time.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Topical tofacitinib is effective and safe for treating alopecia areata.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

In 2017, Spanish dermatologists most often prescribed minoxidil and finasteride for male hair loss, and minoxidil and oral contraceptives for premenopausal female hair loss.

Hair transplantation for men has improved, offering natural, lasting results, and may be enhanced by certain medications and future technologies.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Platelet-Rich Plasma (PRP) therapy can effectively treat various hair loss conditions, improve hair count, thickness, and density, and potentially speed up results when combined with surgical techniques.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

A 2-year-old boy grew excessive hair after using minoxidil for hair loss, but it improved when the treatment stopped.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Topical valproate can effectively promote hair growth.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Cosmeceuticals may have potential but their effectiveness and market success are still uncertain.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.